🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢 FRPT 2022 Webcast - FLASH in Pre-Clinical and Clinical Settings 📌 In this session James Metz, professor of #RadiationOncology at the University of Pennsylvania talks about the future of Proton FLASH radiation. ➡️ bit.ly/44BYR6F #FRPT2023

Thank you to our faculty for sharing insights on paediatric sarcomas and skin cancers on Day 2 of our symposium! Valerie Yang MBBChir PhD Wong Ru Xin Ong Chin-Ann Johnny Claramae Chia Jolene Wong Dirk Strauss Marco Fiore, MD, FACS, FEBSh Alona Zer

Amazing translational research presented by Valerie Yang MBBChir PhD ‘s Lab and colleagues Tan Boon, Wong Ru Xin and more..in the Singapore Sarcoma & Skin Symposium 2025 symposium. So inspiring to meet these young MD, PhD and and postgraduate students and hear about the future of #sarcoma research.

A full house at 1st SingHealth Sarcoma and Skin Symposium at the National Cancer Centre Singapore, 19-20 July 2023. Wonderful to see so many people from all walks of life dedicated towards improving outcomes for our patients with #Sarcoma or #Skin Cancers! #rarecancer

Kudos to authors. Unclear role for most craniopharyngiomas w/ this drug combo. Recent NEJM paper on craniopharyngioma with BRAF-MEK inh: nejm.org/doi/full/10.10… Just take a momment to compare this to a much larger phase 2 trial of protons/photons. ASTRO The New York Times

Will be signing up for this! Exciting times ahead especially after Fast-01. Eagerly awaiting Fast-02 and more clinical studies

🎙 SBRT for #sarcoma 🫁metastases achieved high rates of local control w/ low toxicity❗️🚨OncoAlert @RadiotherapyOn1 📌retro single 🏥study 🥇🎯: Local failure 📊RESULTs 👉66 👥w/ 95 🫁metastases 👉local failure at 12 & 24 m 3.1% &7.4% 👉OS at 12 & 24 m 74% & 49%

🎙️Proton may be more effective and safer than photon therapy for 🫂 w/ #esophagealcancer ‼️ OncoAlert JAMA Network Open 📌 Meta-analysis studies w/ dosimetric/prognosis/and toxic effects outcomes 🥇🎯:Proton vs. photon therapy efficacy and safety; 📊RESULTs 👉Proton ⬇️ OARs

Always love @drdavidpalma talks about treatment of oligomets. 🔥 Pearls on pt selection, dosing considerations, and low likelihood of significant toxicity with careful planning. 🔑 points: ⭐️treat all oligomets when possible ⭐️looking for abscopal likely low yield #ASTRO23

Widely metastatic cancers with high risk asymptomatic bone mets randomized to RT versus SOC. RT is a/w lower skeletal events. ascopubs.org/doi/abs/10.120…

55Gy/20# may be the next standard of care for HN SCC (non HPV).

今週はシンガポール🇸🇬やオーストラリア🇦🇺で放射線治療に従事されている先生方が、研修に来られています✨ 昨日は三人の先生方の施設の紹介をしていただきました。 海外の施設の大きさに圧倒されることもあり、貴重な時間になりました。 #神戸陽子線 #粒子線治療 #切らないがん治療 #小児がん治療

Learnt so much and saw so many rare and interesting cases in a week! Great place, with highly trained staff. Model radiotherapy center for the world to emulate.

Updated OPRA trial studying Total Neoadjuvant Therapy in stage 2/3 rectal cancer. TME-free survival 54% CRT-CNCT group. ascopubs.org/doi/abs/10.120…

Bone Met week 4/5 Any benefit RT for asymptomatic high-risk bone mets? Randomized Trial Prophylactic RT less skeletal events/hospitalizations (& improved OS) compared to standard of care (SOC) ascopubs.org/doi/10.1200/JC…

Bone Met week 5/5 Any benefit RT for Asymptomatic bone mets? · Median time to Mod/Severe pain or SRE: 81 mos EBRT vs 25 mos SOC apm.amegroups.org/article/view/2…

New article (Vol. 191) Which tumour factors preclude organ preservation in patients with rectal cancer? Anna Hołdakowska et al. doi.org/10.1016/j.rado… thegreenjournal.com/article/S0167-…

🎉Our latest publication reveals a cost-effective approach to treating bulky sarcoma recurrences, using low dose rate pulses of VMAT arcs to reduce toxicities in re-irradiation💡 e-roj.org/journal/view.p… #SarcomaTreatment #CostEffective #RadiotherapyResearch

Phase I/II Dose Escalation Trial Chordomas/Chondrosarcomas of Skull Base & C-Spine · No benefit dose escalation · More convincing no benefit as dose escalation in more modern era (better imaging, surgery, proton therapy) sciencedirect.com/science/articl…